Related Experiment Videos
[Retinal manifestations of AIDS]
N Cassoux1, I Reux, Y Guex-Crosier
1Service d'ophtalmologie, Groupe hospitalier Pitié-Salpêtrière, Paris.
La Revue Du Praticien
|September 15, 1996
Summary
Cytomegalovirus (CMV) retinitis, a leading cause of blindness in AIDS patients, requires vigilant screening due to asymptomatic presentation. Virostatic therapies effectively manage CMV retinitis progression and delay relapses.
Area of Science:
- Ophthalmology
- Infectious Diseases
- Immunology
Context:
- Cytomegalovirus (CMV) retinitis is the most frequent opportunistic retinal infection in individuals with Acquired Immunodeficiency Syndrome (AIDS).
- It is strongly correlated with a CD4+ lymphocyte count below 50 cells/microL.
- A significant percentage (54%) of cases are asymptomatic, underscoring the need for regular ophthalmoscopic screening.
Purpose:
- To discuss the clinical significance, diagnosis, and management of Cytomegalovirus (CMV) retinitis in AIDS patients.
- To highlight the importance of early detection and treatment to prevent vision loss.
Summary:
- CMV retinitis is a major cause of blindness in AIDS patients, often asymptomatic and linked to low CD4 counts.
- Approved virostatic drugs like Ganciclovir (Cymevan) and Foscarnet (Foscavir) are effective for induction and maintenance therapy, preventing lesion progression and delaying relapses.
- Differential diagnosis includes various infectious and neoplastic conditions affecting the retina.
Impact:
- Emphasizes the critical role of frequent screening for early detection of CMV retinitis in immunocompromised individuals.
- Informs about current therapeutic strategies for CMV retinitis, improving patient outcomes and vision preservation.
- Provides a comprehensive overview for clinicians managing complex ocular infections in AIDS patients.